Min Zhuo Selected Research

N-Methyl-D-Aspartate Receptors (NMDA Receptors)

3/2019	NMDA Receptor Dependent Long-term Potentiation in Chronic Pain.
3/2016	Neural Mechanisms Underlying Anxiety-Chronic Pain Interactions.
1/2016	Synaptic plasticity in the anterior cingulate cortex in acute and chronic pain.
5/2013	An increase in synaptic NMDA receptors in the insular cortex contributes to neuropathic pain.
7/2011	Post-translational modification of NMDA receptor GluN2B subunit and its roles in chronic pain and memory.
10/2009	Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain.
5/2009	Enhanced synaptic long-term potentiation in the anterior cingulate cortex of adult wild mice as compared with that in laboratory mice.
2/2009	Plasticity of NMDA receptor NR2B subunit in memory and chronic pain.
4/2007	Pharmacological isolation of postsynaptic currents mediated by NR2A- and NR2B-containing NMDA receptors in the anterior cingulate cortex.
12/2006	Forebrain NMDA receptors contribute to neuronal spike responses in adult mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Zhuo Research Topics

Disease

58	Pain (Aches) 01/2022 - 02/2002
33	Chronic Pain 01/2022 - 08/2006
14	Neuralgia (Stump Neuralgia) 01/2022 - 01/2004
10	Fragile X Syndrome (Martin Bell Syndrome) 01/2020 - 04/2008
9	Peripheral Nerve Injuries 01/2018 - 07/2003
8	Hyperalgesia 01/2021 - 02/2002
6	Inflammation (Inflammations) 08/2014 - 10/2004
5	Mental Disorders (Mental Disorder) 01/2020 - 06/2007
5	Substance-Related Disorders (Drug Abuse) 09/2008 - 11/2002
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2018
4	Hypersensitivity (Allergy) 11/2021 - 05/2015
4	Intellectual Disability (Idiocy) 01/2021 - 11/2009
4	Visceral Pain 01/2020 - 11/2015
4	Phantom Limb (Phantom Limbs) 12/2018 - 12/2012
4	Pruritus (Itching) 09/2013 - 09/2010
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 10/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2019
3	Kidney Diseases (Kidney Disease) 01/2022 - 12/2021
3	Hyperkalemia 01/2022 - 10/2019
3	Chronic Renal Insufficiency 01/2022 - 01/2021
3	AIDS-Related Complex (ARC) 12/2018 - 01/2012
3	Memory Disorders (Memory Loss) 12/2017 - 01/2004
3	Mood Disorders (Mood Disorder) 01/2016 - 08/2010
3	Acute Pain 09/2008 - 11/2002
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2021
2	Heart Failure 01/2022 - 01/2022
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 05/2015
2	Chronic Disease (Chronic Diseases) 01/2021 - 10/2012
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2020 - 06/2014
2	Migraine Disorders (Migraine) 01/2020 - 01/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 05/2019 - 10/2014
2	Wounds and Injuries (Trauma) 01/2018 - 01/2014
2	Neoplasms (Cancer) 01/2016 - 01/2012
2	Peritonitis 01/2012 - 01/2012
2	Body Weight (Weight, Body) 12/2006 - 11/2005
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Myocardial Infarction 01/2022
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022
1	Stroke (Strokes) 01/2022
1	Atrophy 01/2022
1	Atrial Fibrillation 01/2022
1	Infections 01/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2003
17	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2019 - 02/2002
16	Analgesics (Analgesic Drugs)IBA 01/2022 - 06/2008
14	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2022 - 01/2004
11	5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanolIBA 01/2022 - 01/2011
11	PlasticsIBA 01/2020 - 08/2006
10	CalciumIBA 01/2022 - 01/2004
9	Pharmaceutical PreparationsIBA 10/2021 - 06/2007
9	Glutamic Acid (Glutamate)FDA Link 01/2020 - 02/2002
9	Fragile X Mental Retardation ProteinIBA 01/2020 - 04/2008
7	AMPA Receptors (AMPA Receptor)IBA 01/2016 - 09/2005
6	N-Methylaspartate (NMDA)IBA 01/2020 - 02/2002
6	Freund's AdjuvantIBA 08/2014 - 11/2002
5	Calmodulin (Calcium-Dependent Activator Protein)IBA 08/2006 - 01/2004
4	Formaldehyde (Formol)FDA Link 01/2022 - 11/2002
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 10/2019
4	Cyclic AMP (AMP, Cyclic)IBA 01/2021 - 11/2002
4	ZymosanIBA 01/2020 - 06/2014
4	Protein Kinase CIBA 01/2018 - 12/2010
4	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2016 - 04/2008
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 11/2020
3	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021 - 10/2009
3	EnzymesIBA 01/2020 - 10/2009
3	adenylyl cyclase 1IBA 01/2020 - 06/2014
3	Glutamate Receptors (Glutamate Receptor)IBA 01/2017 - 02/2002
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2016 - 07/2008
3	Transcription Factors (Transcription Factor)IBA 01/2012 - 04/2006
3	Peptides (Polypeptides)IBA 09/2011 - 12/2006
3	Calcium-Calmodulin-Dependent Protein Kinase Type 4IBA 10/2008 - 01/2004
2	SodiumIBA 01/2022 - 10/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2021
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 11/2020
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2021 - 05/2015
2	Protein Isoforms (Isoforms)IBA 01/2021 - 02/2006
2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2020
2	Calcitonin Gene-Related PeptideIBA 01/2020 - 01/2019
2	NeuropeptidesIBA 01/2019 - 11/2005
2	Ion Channels (Ion Channel)IBA 01/2018 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 01/2012
2	Kainic Acid Receptors (Kainate Receptor)IBA 01/2016 - 01/2007
2	Gabapentin (Neurontin)FDA LinkGeneric 10/2014 - 06/2014
2	ColforsinIBA 08/2014 - 11/2002
2	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2014 - 06/2002
2	Kainic Acid (Kainate)IBA 09/2013 - 06/2011
2	Histamine (Histamine Dihydrochloride)FDA Link 09/2013 - 12/2011
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 10/2008 - 04/2006
2	Morphine (MS Contin)FDA LinkGeneric 06/2008 - 11/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	patiromerIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	apixabanIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022

Therapy/Procedure

5	Surgical Amputation (Amputations) 01/2022 - 12/2012
3	Analgesia 01/2021 - 01/2016
2	Renal Dialysis (Hemodialysis) 01/2022 - 01/2021
2	Ligation 01/2018 - 11/2005
2	Therapeutics 01/2016 - 03/2012